Oxytetracycline for Injection
» Oxytetracycline for Injection contains an amount of Oxytetracycline Hydrochloride equivalent to not less than 90.0 percent and not more than 115.0 percent of the labeled amount of oxytetracycline (C22H24N2O9).
Packaging and storage— Preserve in Containers for Sterile Solids as described under Injections 1, protected from light.
USP Reference standards 11
USP Endotoxin RS
USP Oxytetracycline RS Click to View Structure
Constituted solution— At the time of use, it meets the requirements for Constituted Solutions under Injections 1.
Bacterial endotoxins 85 It contains not more than 0.4 USP Endotoxin Unit per mg of oxytetracycline.
Sterility 71 It meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined, Fluid D being used instead of Fluid A.
pH 791: between 1.8 and 2.8, in a solution containing 25 mg per mL.
Loss on drying 731 Dry about 100 mg, accurately weighed, in a capillary-stoppered bottle in vacuum at a pressure not exceeding 5 mm of mercury at 60 for 3 hours: it loses not more than 3.0% of its weight.
Particulate matter 788: meets the requirements for small-volume injections.
Other requirements— It responds to Identification test B under Oxytetracycline Hydrochloride. It also meets the requirements for Uniformity of Dosage Units 905 and Labeling under Injections 1.
Assay—
Tetrabutylammonium hydrogen sulfate solution, Edetate disodium solution, pH 7.5 Phosphate buffer, Mobile phase, Standard preparation, System suitability solution, and Chromatographic system— Proceed as directed in the Assay under Oxytetracycline.
Assay preparation 1 (where it is represented as being in a single-dose container)—Constitute Oxytetracycline for Injection in a volume of water, accurately measured, corresponding to the volume of solvent specified in the labeling. Withdraw all of the withdrawable contents, using a suitable hypodermic needle and syringe, and dilute quantitatively with 0.01 N hydrochloric acid to obtain a solution having a concentration of about 0.2 mg of oxytetracycline per mL.
Assay preparation 2 (where the label states the quantity of oxytetracycline in a given volume of constituted solution)—Constitute Oxytetracycline for Injection in a volume of water, accurately measured, corresponding to the volume of solvent specified in the labeling. Dilute an accurately measured volume of the constituted solution quantitatively with 0.01 N hydrochloric acid to obtain a solution having a concentration of about 0.2 mg of oxytetracycline per mL.
Procedure— Proceed as directed for Procedure in the Assay under Oxytetracycline. Calculate the quantity, in mg, of oxytetracycline (C22H24N2O9) withdrawn from the container or in the portion of constituted solution taken by the formula:
(L / D)(CP)(rU / rS)
in which L is the labeled quantity, in mg, of oxytetracycline (C22H24N2O9) in the container or in the portion of constituted solution taken; D is the concentration, in mg per mL, of oxytetracycline in Assay preparation 1 or in Assay preparation 2, based on the labeled quantity in the container or in the portion of constituted solution taken, respectively, and the extent of dilution; and the other terms are as defined therein.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ahalya Wise, M.S.
Senior Scientific Liaison
1-301-816-8161
(SM12010) Monographs - Small Molecules 1
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
85 Radhakrishna S Tirumalai, Ph.D.
Principal Scientific Liaison
1-301-816-8339
(GCM2010) General Chapters - Microbiology
71 Radhakrishna S Tirumalai, Ph.D.
Principal Scientific Liaison
1-301-816-8339
(GCM2010) General Chapters - Microbiology
USP35–NF30 Page 4189